These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1409415)

  • 1. Antigens associated with tumor progression in melanocytic neoplasia.
    Elder DE; Herlyn M
    Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
    White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
    J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on immunohistochemistry in melanocytic lesions.
    Ferringer T
    Dermatol Clin; 2012 Oct; 30(4):567-79, v. PubMed ID: 23021046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions].
    Collina G
    Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373
    [No Abstract]   [Full Text] [Related]  

  • 5. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.
    Jimbow K; Horikoshi T; Takahashi H; Akutsu Y; Maeda K
    J Invest Dermatol; 1989 May; 92(5 Suppl):304S-309S. PubMed ID: 2715663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2.
    Maeda K; Maeda K; Jimbow K
    J Invest Dermatol; 1988 Sep; 91(3):247-50. PubMed ID: 3411143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
    Takahashi H; Strutton GM; Parsons PG
    Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of HLA antigens and lymphocyte infiltration in melanocytic tumors.
    Kageshita T; Nagano H; Johno M; Ono T; Arao T; Imai K
    J Dermatol; 1986 Jun; 13(3):179-84. PubMed ID: 3537044
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphological changes in melanocytic nevi induced by exogenous factors].
    Tronnier M; Alexander M; Neitmann M; Brinckmann J; Wolff HH
    Hautarzt; 2000 Aug; 51(8):561-6. PubMed ID: 10997310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reporting melanocytic lesions: the form, substance, and the void].
    Urso C
    Pathologica; 2001 Jun; 93(3):253-7. PubMed ID: 11433624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
    Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
    G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
    [No Abstract]   [Full Text] [Related]  

  • 13. Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis.
    Bergman W; Ruiter DJ; Scheffer E; van Vloten WA
    Cancer; 1988 Apr; 61(8):1660-6. PubMed ID: 3349425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between keratinocyte proliferative activity, HMB-45 reactivity, and the presence of suprabasal melanocytes in acral nevi.
    Tronnier M; Rasheed A
    Arch Dermatol Res; 1998 Mar; 290(3):167-70. PubMed ID: 9558494
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanocytes of a melanocytic nevus in a lymph node from a patient with a primary cutaneous melanoma associated with a small congenital nevus.
    Hruban RH; Eckert F; Baricević B
    Am J Dermatopathol; 1990 Aug; 12(4):402-7. PubMed ID: 2203272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
    Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
    Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphometry of melanocytic skin lesions--verifications or vexations? A review of a group experience.
    Williams RA
    Pathologica; 1998 Apr; 90(2):183-5. PubMed ID: 9619064
    [No Abstract]   [Full Text] [Related]  

  • 18. [Step-wise expression of melanoma-associated antigens in tumor progression].
    Lehmann JM; Holzmann B; Rothbächer U; Riethmüller G; Johnson JP
    Onkologie; 1989 Dec; 12(6):273-6. PubMed ID: 2696911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical characterization of Spitz's nevus: differentiation from common melanocytic nevus, dysplastic melanocytic nevus and malignant melanoma.
    Takahashi H; Maeda K; Maeda K; Akutsu Y; Horikoshi T; Jimbow K
    J Dermatol; 1987 Dec; 14(6):533-41. PubMed ID: 3329652
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between sialyl Lewis(a) expression and tumor progression in melanoma.
    Kageshita T; Hirai S; Kimura T; Hanai N; Ohta S; Ono T
    Cancer Res; 1995 Apr; 55(8):1748-51. PubMed ID: 7712483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.